Jessica Chubak to Aromatase Inhibitors
This is a "connection" page, showing publications Jessica Chubak has written about Aromatase Inhibitors.
Connection Strength
0.026
-
Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract. 2012 Nov; 8(6):e149-57.
Score: 0.026